Escherichia Coli Bacteria
- All
- News
-
Plastic To Paracetamol: Scientists Convert Waste Into Painkiller In 24 Hours
- Tuesday June 24, 2025
- Science | Edited by Nikhil Pandey
Scientists at the University of Edinburgh have developed a process using E. coli bacteria to convert PET plastic waste into paracetamol, offering a sustainable alternative to traditional drug manufacturing methods that rely on fossil fuels.
-
www.ndtv.com
-
Researchers Find Second 'Superbug' Gene In US Patient
- Tuesday June 28, 2016
- World News | Reuters
Scientists have identified a second patient in the United States infected with bacteria carrying the mcr-1 "superbug" gene, which makes bacteria highly resistant to a last-resort class of antibiotics.
-
www.ndtv.com
-
New anthrax vaccine from India
- Friday November 16, 2001
- Team DoctorNDTV
A new, experimental human anthrax vaccine developed in India is ready and waiting for clinical trials, according to Dr. Rakesh Bhatnagar, chairman of the Centre for Biotechnology (CBT) at the Jawaharlal Nehru University in New Delhi. The CBT team genetically engineered Escherichia coli (E. coli) bacteria to produce harmless, mutant forms of the t...
-
doctor.ndtv.com
-
Plastic To Paracetamol: Scientists Convert Waste Into Painkiller In 24 Hours
- Tuesday June 24, 2025
- Science | Edited by Nikhil Pandey
Scientists at the University of Edinburgh have developed a process using E. coli bacteria to convert PET plastic waste into paracetamol, offering a sustainable alternative to traditional drug manufacturing methods that rely on fossil fuels.
-
www.ndtv.com
-
Researchers Find Second 'Superbug' Gene In US Patient
- Tuesday June 28, 2016
- World News | Reuters
Scientists have identified a second patient in the United States infected with bacteria carrying the mcr-1 "superbug" gene, which makes bacteria highly resistant to a last-resort class of antibiotics.
-
www.ndtv.com
-
New anthrax vaccine from India
- Friday November 16, 2001
- Team DoctorNDTV
A new, experimental human anthrax vaccine developed in India is ready and waiting for clinical trials, according to Dr. Rakesh Bhatnagar, chairman of the Centre for Biotechnology (CBT) at the Jawaharlal Nehru University in New Delhi. The CBT team genetically engineered Escherichia coli (E. coli) bacteria to produce harmless, mutant forms of the t...
-
doctor.ndtv.com